These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7974024)

  • 21. Intravenous pulse methylprednisolone therapy in eye disease: effect on glucose tolerance.
    Feldman-Billard S; Lissak B; Benrabah R; Kassaei R; Héron E
    Ophthalmology; 2003 Dec; 110(12):2369-71. PubMed ID: 14644720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The one-and-a-half syndrome in systemic lupus erythematosus.
    Yiğit A; Bingöl A; Mutluer N; Taşçilar N
    J Neuroophthalmol; 1996 Dec; 16(4):274-6. PubMed ID: 8956164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute central nervous system complications after pulse steroid therapy in patients with systemic lupus erythematosus.
    Wysenbeek AJ; Leibovici L; Zoldan J
    J Rheumatol; 1990 Dec; 17(12):1695-6. PubMed ID: 2084249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A high-dose pulse steroid regimen for controlling active chronic graft-versus-host disease.
    Akpek G; Lee SM; Anders V; Vogelsang GB
    Biol Blood Marrow Transplant; 2001; 7(9):495-502. PubMed ID: 11669216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous monthly pulse methylprednisolone treatment for ABPA in patients with cystic fibrosis.
    Cohen-Cymberknoh M; Blau H; Shoseyov D; Mei-Zahav M; Efrati O; Armoni S; Kerem E
    J Cyst Fibros; 2009 Jul; 8(4):253-7. PubMed ID: 19447081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
    Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
    Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Central nervous system manifestations in juvenile systemic lupus erythematosus: a problem of management.
    Davies UM; Ansell BM
    J Rheumatol; 1988 Nov; 15(11):1720-1. PubMed ID: 3236306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
    Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
    Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren syndrome.
    Marsh P; Pflugfelder SC
    Ophthalmology; 1999 Apr; 106(4):811-6. PubMed ID: 10201607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus.
    Baca V; Lavalle C; García R; Catalán T; Sauceda JM; Sánchez G; Martínez I; Ramírez ML; Márquez LM; Rojas JC
    J Rheumatol; 1999 Feb; 26(2):432-9. PubMed ID: 9972981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Long-term study of diffuse connective tissue disease after methylprednisolone pulsed therapy].
    Hrncír Z; Bradna P; Nozicková H; Tichý M
    Vnitr Lek; 1991 Jan; 37(1):63-72. PubMed ID: 2058099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pneumatosis cystoides intestinalis associated with intravenous pulse cyclophosphamide treatment for systemic lupus erythematosus].
    Nonaka D; Higuchi M; Yoshizawa S; Horiuchi T; Nakashima H; Niho Y
    Ryumachi; 1998 Aug; 38(4):605-10. PubMed ID: 9785989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylprednisolone suleptanate Pharmacia Corp.
    Paggiaro P
    Curr Opin Investig Drugs; 2000 Sep; 1(1):97-103. PubMed ID: 11249603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful treatment of Stevens-Johnson syndrome with steroid pulse therapy at disease onset.
    Araki Y; Sotozono C; Inatomi T; Ueta M; Yokoi N; Ueda E; Kishimoto S; Kinoshita S
    Am J Ophthalmol; 2009 Jun; 147(6):1004-11, 1011.e1. PubMed ID: 19285657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.
    Mazlumzadeh M; Hunder GG; Easley KA; Calamia KT; Matteson EL; Griffing WL; Younge BR; Weyand CM; Goronzy JJ
    Arthritis Rheum; 2006 Oct; 54(10):3310-8. PubMed ID: 17009270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of intravenous megadoses of methylprednisolone for treatment of dermatomyositis in children].
    Romicka AM
    Pediatr Pol; 1995 Mar; 70(3):243-8. PubMed ID: 8657493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous methylprednisolone pulse therapy in ankylosing spondylitis.
    Ejstrup L; Peters ND
    Dan Med Bull; 1985 Aug; 32(4):231-3. PubMed ID: 4042697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Methylprednisolone shock dose therapy of systemic lupus erythematosus with central nervous system involvement].
    Alekberova ZS; Folomeeva OM; Savinov VA; Berezova NIu
    Vopr Revm; 1981; (4):60-1. PubMed ID: 7331277
    [No Abstract]   [Full Text] [Related]  

  • 39. Pulse methylprednisolone in SLE.
    Kimberly RP
    Clin Rheum Dis; 1982 Apr; 8(1):261-78. PubMed ID: 6749399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The diagnosis and steroid "pulse" therapy of systemic lupus erythematosus associated with mental disturbances in the general hospital.
    Li S; Wang J
    Chin Med Sci J; 1992 Dec; 7(4):235-8. PubMed ID: 1307501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.